Immune Pharma (IMNP) Tops Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Immune Pharmaceuticals Announces Corporate Update; Second Quarter 2015 Financial Results and Highlights and Conference Call Details
August 17, 2015 6:30 AM EDTNEW YORK, Aug. 17, 2015 /PRNewswire/ --Â Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ("Immune" or the "Company") announces corporate update and financial results for second quarter and six months ended June 30, 2015.
Second Quarter 2015; Recent Highlights and Upcoming Milestones
The Company made progress during the second quarter of 2015 in executing its business plan as well as closing, after the end of the quarter, on a significant financing of up to $21.5 million in gross proceeds, as previously announced on July 29, 2015.
"We believe that Immune's recent announcement on securing these financings will... More
